MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202647095241 A) filed by Abcentra, LLC on August 06, 2026, for Compositions And Methods For Reducing Risk Of Major Adverse Cardiovascular Event.
Inventor includes Farina, Christopher John.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The disclosure provides methods of reducing the risk of a major adverse cardiovascular event (MACE) in a subject having previously experienced acute coronary syndrome (ACS) and for reducing risk of a MACE in a patient who is diagnosed with coronary artery disease and has blood high-sensitivity C- reactive (hs-CRP) of 2.0 mg/L. The methods include administering to the subject an anti-oxLDL antibody. The anti-oxLDL antibody may be administered to the subject alone or in combination with one or more additional therapeutic agents, such as one or more lipid lowering agents.
Disclaimer: Curated by HT Syndication.
